Obesity drug Wegovy’s popularity has US employers rethinking insurance coverage
By Patrick Wingrove (Reuters) – Shawnte struggled with her weight for years before she was prescribed Novo Nordisk’s diabetes drug Ozempic for weight loss in 2020, helping the former music industry professional from New York lose more than 50 pounds over two years. But last year, the 46-year-old, who asked to be identified only by…
